Skip to main content
Oncotarget logoLink to Oncotarget
. 2021 Aug 31;12(18):1859–1860. doi: 10.18632/oncotarget.28066

Correction: MicroRNA-126 inhibits tumor proliferation and angiogenesis of hepatocellular carcinoma by down-regulating EGFL7 expression

Ming-Hua Hu 1, Chen-Yang Ma 1, Xiao-Ming Wang 1, Chen-Dong Ye 2, Guang-Xian Zhang 1, Lin Chen 1, Jin-Guo Wang 1,
PMCID: PMC8416556  PMID: 34504658

This article has been corrected: The image in Figure 8, panel A is an accidental duplicate of the image in Figure 8, panel E. The corrected Figure 8, obtained using the original data, now shows the proper panel A. The authors declare that these corrections do not change the results or conclusions of this paper.

Figure 8. The VEGF-positive rate of transplanted tumors in nude mice among different groups detected by immunohistochemistry (× 200).

Figure 8

(A) The blank group; (B) The miR-126 mimics group; (C) The miR-126 inhibitors group; (D) The si-EGFL7 group; (E) The miR-126 inhibitors + si-EGFL7 group.

Original article: Oncotarget. 2016; 7:66922–66934. 66922-66934. https://doi.org/10.18632/oncotarget.11877


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES